FLUSPIRILENE, AN INJECTABLE, AND PENFLURIDOL, AN ORAL LONG‐ACTING, NEUROLEPTIG: A comparative double‐blind trial in residual schizophrenia

Acta Psychiatrica Scandinavica

Volumn 48, Issue 4, 1972, Pages 315-331

  Tanghe, A ^a   Th M Vereecken, J L ^b  

^a Psychiatric Unit ^*

^b De Grote Rivieren   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DELAYED ACTION PREPARATIONS; PIPERIDINE DERIVATIVE; PLACEBO; TRANQUILIZER;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LENGTH OF STAY; OCCUPATIONAL THERAPY; ORAL DRUG ADMINISTRATION; PSYCHOLOGIC TEST; QUESTIONNAIRE; RATING SCALE; SCHIZOPHRENIA;

ADMINISTRATION, ORAL; ADULT; AGED; CHRONIC DISEASE; CLINICAL TRIALS; DELAYED-ACTION PREPARATIONS; EVALUATION STUDIES; FEMALE; HUMAN; INJECTIONS, INTRAMUSCULAR; INTERVIEW, PSYCHOLOGICAL; LENGTH OF STAY; MIDDLE AGE; OCCUPATIONAL THERAPY; PIPERIDINES; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SCHIZOPHRENIA; TRANQUILIZING AGENTS;

EID: 0015452969     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1972.tb04372.x     Document Type: Article

References (29)

1. Fluspirilene: a new long‐acting injectable neuroleptic
2. Maintenance therapy of chronic psychotic patients with a weekly oral dose of R 16341. A controlled double‐blind study
3. Neuroleptiques à longue durée d'action. Etude pilote du penfluridol (R 16341)
4. Fluspirilene in the treatment of chronic schizophrenic patients
5. Kontrole op de inname van medicijnen
6. Dexbenzetimide in neuroleptic‐induced parkinsonism. A double‐blind cross‐over study with a 16‐week follow‐up
7. A quantitative study of neuroleptic‐induced extrapyramidal symptoms and their response to dexetimide, a potent and long‐acting antiparkinsonian agent
8. Defect schizophrenic states (residual schizophrenia). A clinical study prompted by K. Leonhard's classification
9. Experience with fluspirilene (R 6218), a long‐acting neuroleptic
10. Klini‐sche Prüfung eines neuen Langzeitneuroleptikums (Fluspirilene) unter besonderer Beriicksichtigung der neuroleptischen Schwelle
11. A rating scale of the mental state for use in the chronic population of the psychiatric hospital
12. Klinische Gemeinschaftsuntersuchung mit dem Langzeit‐Neurolepticum Fluspirilene
13. The pharmacology of fluspirilene (R 6218), a potent, long‐acting and injectable neuroleptic drug
14. The pharmacology of penfluridol (R 16341), a new potent and orally long‐acting neuroleptic drug
15. Het gebruik van een inspuitbaar neurolepticum met lange werkingsduur‐fluspirilene (R6218)‐ter voorkoming van recidiven bij chronische schizofrenen
16. Um nôvo atáráxico de ação prolongada‐oR 6218, e o contrôle dos seus efeitos extrapiramidais com um nôvo agente antiparkinsoniano–oR 4929
17. Clinical study of an injectable long‐acting neuroleptic agent: fluspirilene (R6218)
18. Standard psychiatric symptom description: the Factor Construct Rating Scale (FCRS)
19. Fluspirilene (R 6218), een nieuw inspuitbaar depot‐neurolepticum. Een onderzoek naar zijn klinische werkzaamheid en zijn veiligheid
20. A controlled trial of penfluridol‐an orally long‐acting neuroleptic drug‐in acute psychosis
21. Clinical evaluation of fluspirilene (R 6218), a long‐acting injectable neuroleptic
22. Clinical and ergotherapeutic evaluation of fluspirilene (R6218), a long‐acting injectable neuroleptic, in chronic psychotic patients
23. Fluspirilene and pipothiazine undecylenate, two long‐acting injectable neuroleptics. A double‐blind controlled trial in residual schizophrenia
24. A controlled study of fluspirilene in chronic schizophrenia
25. Clinical evaluation of the long‐acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally‐retarded patients